JMP Securities Downgrades Myriad Genetics (MYGN) to Market Perform
Tweet Send to a Friend
JMP Securities downgraded Myriad Genetics (NASDAQ: MYGN) from Market Outperform to Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
